The Mark Foundation for Cancer Research will execute a grant agreement with each Awardee’s institution. The policies stated herein are for informational purposes and do not reflect all the terms that may be incorporated into that agreement.
The Grant shall be used by Awardee only for the purpose of carrying out research in accordance with the Awardee’s project plan. The approved project plan will serve as an appendix to the Grant Agreement.
The initial payment will be made within fifteen days from the date of execution. Payment schedules are determined by the Grant term and reports as described below.
Progress Reports: Scientific progress reports are due to The Mark Foundation one month after each anniversary of the start date of the Grant term (the final reports are due two months after the end date of the Grant term). Each report will summarize the progress made in accomplishing the aims of the project plan during the reporting period. Submitted reports will be evaluated based on the pace of work completed toward achievement of the aims. All reports will be treated as confidential. Reports may be reviewed by outside experts. Templates will be provided to the Awardee approximately one month before the due date.
The second-year progress report may be accompanied by a presentation either in-person or via video conference.
Final reports will include a summary of the full term of the Grant including an impact statement describing the value of the work to the field and the Grant to the Awardee.
Finance Reports: The Awardee’s institution will provide a finance report due within one month after each anniversary of the start date of the Grant term with the final report due two months after the end date of the Grant term. Reports will summarize how Grant funds were spent based on the approved budget. A template will be provided to the Awardee approximately one month before the due date. Each finance report must be attested to by a responsible financial officer of the institution.
Additional Reports: On rare occasions, The Mark Foundation may request additional reports to monitor progress made in achievement of the Grant project plan. If additional reports are requested, the Awardee will be provided with the specific details and/or forms for the reports at least one month in advance of the due date.
PLEASE NOTE: Failure to submit a final report may exclude the Awardee and/or the Awardee’s institution from eligibility for future funding from The Mark Foundation.
Institutional Assurances: All work under the Grant must be in compliance with institutional, federal, state and local regulations. Any use of human or animal subjects or biohazardous material must be disclosed at the time of application. All required assurances must be provided to The Mark Foundation prior to initial payment. Payments may be withheld in cases in which approvals have expired and renewals have not been provided. Awardee is encouraged to promptly submit renewed approval documentation.
Budget Adjustments: Awardee must inform The Mark Foundation if there are significant changes in the purposes of the Grant, the use of Grant funds, or if the Grant funds cannot be expended in the time period covered by the Grant. No portion of the Grant funds may be used for purposes other than those specified in the project plan unless The Mark Foundation has provided advanced written permission. Budget revision requests will be considered but changes cannot exceed the stated caps described above. Budget revision requests are not necessary when shifting funds within a single category up to 15 percent.
No Cost Extension: When funds are not anticipated to be fully dispersed, no cost extensions may be requested at least two months before the end date of the Grant term. For consideration, the institution must provide The Mark Foundation with the approximate amount of remaining funds, the reason for the delayed spending, an adjusted budget, and an interim finance report.
Change of Research Direction: The Mark Foundation acknowledges that scientific research is not always predictable. Any substantial changes to the project plan must include a budget revision and be submitted for approval.
Transfer of Institution: The Grant is provided to the institution of the Awardee. In the event that the Awardee changes institutions, The Mark Foundation should be informed of the move as early as possible. The Grant will terminate at the original institution and unexpended funds and the final finance report will be two months after the Grant terminates. The Mark Foundation may consider written requests for Grant transfers from the Awardee. At The Mark Foundation’s discretion, a new Grant with the remaining funds may be initiated once unexpended funds are returned from the original institution.
Ownership: The Awardee and/or the Awardee’s institution will own all right, title, and interest in and to all inventions and the right to file any patent or legal protection as stipulated by the institution’s policies. The Mark Foundation must be informed in a timely and detailed manner of any such IP that has been disclosed and/or filed by the Awardee and/or the institution.
Commercialization: The Mark Foundation must be informed in a timely and detailed manner of any commercialization efforts with respect to project IP.
Diligence: If the development or commercialization of any project IP that could improve outcomes for cancer patients has not been diligently pursued within a mutually agreeable time period, then at The Mark Foundation’s request the Awardee and/or Awardee’s institution will grant The Mark Foundation a license to do so.
Data sharing: In furtherance to our mission, The Mark Foundation takes an active approach to ensuring outcomes from our funding benefit the patient community by encouraging widespread and rapid data sharing. The Mark Foundation expects project data to be made available to research community within eighteen months of the end date of the Grant term at no cost for non-commercial use to advance the understanding of cancer and to maximize scientific and patient impact.
Scientific publications: When any work under this Grant is published in a scientific journal, funding from The Mark Foundation should be acknowledged with the line, “Supported (in part) by an Emerging Leader Award from The Mark Foundation for Cancer Research (grant #).” A manuscript must be provided to The Mark Foundation at the time of acceptance by a journal.
Presentations: When any work under this Grant is reported during a presentation, funding from The Mark Foundation must be acknowledged, and an approved logo graphic included as appropriate.
Media: Press releases or other public announcements of any work under this Grant require written consent of The Mark Foundation.